The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
The normal structure and function of CD44 and its role in neoplasia
Open accessAbstract
CD44 is a transmembrane glycoprotein, the variant isoforms of which are coded for by alternative splicing, with the most prolific isoform being CD44 standard. CD44 is found in a wide variety of tissues including the central nervous system, lung, epidermis, liver, and pancreas, whereas variant isoforms of CD44 (CD44v) appear to have a much more restricted distribution. Variants of CD44 are expressed in tissues during development, including embryonic epithelia. Known functions of CD44 are cellular adhesion (aggregation and migration), hyaluronate degradation, lymphocyte activation, lymph node homing, myelopoiesis and lymphopoiesis, angiogenesis, and release of cytokines. The functions of CD44 are principally dependant on cellular adhesion in one setting or another. The role of CD44 in neoplasia is less well defined, although metastatic potential can be conferred on non-metastasising cell lines by transfection with a variant of CD44 and high levels of CD44 are associated with several types of malignant tumours. The physiological functions of CD44 indicate that the molecule could be involved in the metastatic spread of tumours. Many studies have investigated the pattern of CD44 distribution in tumours and some observations suggest that certain cells do not use CD44 in tumorigenesis or in the production of metastases. However, the data are extremely conflicting, and further studies are needed to establish the prognostic value of CD44 and its variant isoforms. The precise function of CD44 in the metastatic process and the degree of involvement in human malignancies has yet to be established fully.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Proteoglycans: many forms and many functions
Hardingham, T. E., & Fosang, A. J. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.3.1740236 · Cited by 1,195
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
Osteopontin--a possible anchor of osteoclasts to bone.
Reinholt, F. P., Hultenby, K., Oldberg, A., & Heinegård, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4473 · Cited by 824
Wayner, E. A., & Carter, W. G. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.4.1873 · Cited by 715
Stamenkovic, I., Amiot, M., Pesando, J. M., & Seed, B. (1989) · Cell · doi:10.1016/0092-8674(89)90638-7 · Cited by 672
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
Stamenkovic, I., Aruffo, A. A., Amiot, M., & Seed, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07955.x · Cited by 573
CD44 — A molecule involved in leukocyte adherence and T-cell activation
Haynes, B. F., Telen, M. J., Hale, L. P., & Denning, S. M. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90040-6 · Cited by 549
Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures.
Miyake, K., Medina, K. L., Hayashi, S., Ono, S., Hamaoka, T., & Kincade, P. W. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.477 · Cited by 544
Jalkanen, S., Bargatze, R. F., de los Toyos, J., & Butcher, E. C. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.2.983 · Cited by 531
Cell surface heparan sulfate proteoglycans.
Yanagishita, M., & Hascall, V. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50108-9 · Cited by 474
Expression and modulation of CD44 variant isoforms in humans
Mackay, C., Terpe, H., Stauder, R., Marston, W., Stark, H., & Günthert, U. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.71 · Cited by 437
Bennett, K. L., Jackson, D. G., Simon, J. C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., & Aruffo, A. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.687 · Cited by 427
Jalkanen, S. T., Bargatze, R. F., Herron, L. R., & Butcher, E. C. (1986) · European Journal of Immunology · doi:10.1002/eji.1830161003 · Cited by 416
Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44
Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., & Zöller, M. (1992) · Science · doi:10.1126/science.1496383 · Cited by 403
Yang, B., Yang, B. L., Savani, R. C., & Turley, E. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06261.x · Cited by 383
Identification of hyaluronic acid binding sites in the extracellular domain of CD44
Peach, R., Hollenbaugh, D., Stamenkovic, I., & Aruffo, A. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.257 · Cited by 378
Brown, T. A., Bouchard, T., St John, T., Wayner, E., & Carter, W. G. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.207 · Cited by 368
West, D. C., & Kumar, S. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90428-x · Cited by 357
CD44 variant exon epitopes in primary breast cancer and length of survival
Kaufmann, M., von Minckwitz, G., Heider, K.-H., Ponta, H., Herrlich, P., & Sinn, H.-P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90521-9 · Cited by 353
Heider, K. H., Hofmann, M., Hors, E., van den Berg, F., Ponta, H., Herrlich, P., & Pals, S. T. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.1.227 · Cited by 342
Trowbridge, I. S., Lesley, J., Schulte, R., Hyman, R., & Trotter, J. (1982) · Immunogenetics · doi:10.1007/bf00364338 · Cited by 341
Hofmann‐Apitius, M., Rudy, W., Zöller, M., Tölg, C., Ponta, H., Herrlich, P. A., & Günthert, U. (1991) · PubMed · doi:10.5451/unibas-ep6484 · Cited by 338
Prevention of tumor metastasis formation by anti-variant CD44.
Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., & Zöller, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.443 · Cited by 334
Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.53 · Cited by 331
CD44 contributes to T cell activation.
Huet, S., Groux, H., Caillou, B., Valentin, H., Prieur, A. M., & Bernard, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.3.798 · Cited by 318
Dual role of the CD44 molecule in T cell adhesion and activation.
Shimizu, Y., Van Seventer, G. A., Siraganian, R., Wahl, L., & Shaw, S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2457 · Cited by 318
Adhesion molecules in tumor metastasis.
Zetter, B. R. (1993) · PubMed · Cited by 318
Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Fox, S. B., Fawcett, J., Jackson, D. G., Collins, I., Gatter, K. C., Harris, A. L., Gearing, A. J. H., & Simmons, D. L. (1994) · PubMed · Cited by 304
Koopman, G., Heider, K. H., Horst, E., Adolf, G. R., van den Berg, F., Ponta, H., Herrlich, P., & Pals, S. T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.897 · Cited by 298
LFA-3, CD44, and CD45: Physiologic Triggers of Human Monocyte TNF and IL-1 Release
Webb, D. S. A., Shimizu, Y., Van Seventer, G. A., Shaw, S., & Gerrard, T. L. (1990) · Science · doi:10.1126/science.1697984 · Cited by 287
Faassen, A. E., Schrager, J. A., Klein, D. J., Oegema, T. R., Couchman, J. R., & McCarthy, J. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.2.521 · Cited by 280
Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
Katoh, S., Zheng, Z., Oritani, K., Shimozato, T., & Kincade, P. W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.419 · Cited by 254
Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R., & Kincade, P. W. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.257 · Cited by 247
De-novo expression of CD44 and survival in gastric cancer
Mayer, B., Jauch, K. W., Schildberg, F. W., Funke, I., Günthert, U., Figdor, C. G., & Johnson, J. P. (1993) · The Lancet · doi:10.1016/0140-6736(93)92879-x · Cited by 238
The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms.
Haynes, B. F., Liao, H., & Patton, K. L. (1991) · PubMed · Cited by 227
Singh, R. P., Patarca, R., Schwartz, J., Singh, P., & Cantor, H. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.6.1931 · Cited by 226
Trochon, V., Mabilat, C., Bertrand, P., Legrand, Y., Smadja-Joffe, F., Soria, C., Delpech, B., & Lu, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960529)66:5<664::aid-ijc14>3.0.co;2-4 · Cited by 211
Lesley, J., Schulte, R., & Hyman, R. (1990) · Experimental Cell Research · doi:10.1016/0014-4827(90)90085-o · Cited by 203
CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
Gao, A. C., Lou, W., Dong, J., & Isaacs, J. T. (1997) · PubMed · Cited by 197
Manten‐Horst, E., Meijer, C. J. L. M., Radaszkiewicz, T., Ossekoppele, G., van Krieken, J. H., & Pals, S. T. (1990) · PubMed · Cited by 183
Birch, M., Mitchell, S., & Hart, I. R. (1991) · PubMed · Cited by 182
Cell Aggregation: Role of Acid Mucopolysaccharides
Pessac, B., & Defendi, V. (1972) · Science · doi:10.1126/science.175.4024.898 · Cited by 181
Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
Guo, Y., Ma, J., Wang, J., Che, X., Narula, J., Bigby, M. E., Wu, M., & Sy, M. (1994) · PubMed · Cited by 165
Bourguignon, L., Lokeshwar, V. B., Chen, X., & Kerrick, W. G. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.12.6634 · Cited by 162
Culty, M., Shizari, M., Thompson, E. W., & Underhill, C. B. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600209 · Cited by 161
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D. G., Spring, F. A., & Aruffo, A. A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1623 · Cited by 155
Hofmann‐Apitius, M., Rudy, W., Günthert, U., Zimmer, S. G., Zawadzki, V., Zöller, M., Lichtner, R. B., Herrlich, P., & Ponta, H. (1993) · PubMed · doi:10.5451/unibas-ep6483 · Cited by 147
CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells
Lesley, J., & Hyman, R. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221036 · Cited by 142
Lees, V. C., Fan, T. P., & West, D. C. (1995) · PubMed · Cited by 138
Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.
Jain, M. K., He, Q. W., Lee, W. S., Kashiki, S., Foster, L. C., Tsai, J. C.-S., Lee, M. E., & Haber, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118455 · Cited by 133
Osteopontin-Stimulated Vascular Smooth Muscle Cell Migration Is Mediated by β3 Integrin
Yue, T.-L., McKenna, P., Ohlstein, E. H., et al. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1282 · Cited by 129
Idzerda, R. L., Carter, W. G., Nottenburg, C., Wayner, E. A., Gallatin, W. M., & John, T. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4659 · Cited by 127
Lesley, J., Kincade, P. W., & Hyman, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230826 · Cited by 121
Underhill, C. B., & Toole, B. P. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85527-8 · Cited by 108
Receptors for hyaluronate on the surface of parent and virus-transformed cell lines
Underhill, C. B., & Toole, B. P. (1981) · Experimental Cell Research · doi:10.1016/0014-4827(81)90248-2 · Cited by 104
Underhill, C. B., Green, S. J., Comoglio, P. M., & Tarone, G. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45179-4 · Cited by 103
Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
Zahalka, M. A., Okon, E., Gosslar, U., Holzmann, B., & Naor, D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5345 · Cited by 102
Neame, S. J., & Isacke, C. M. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.6.1299 · Cited by 100
Yamaguchi, A., Urano, T., Goi, T., Saito, M., Takeuchi, K., Hirose, K., Nakagawara, G., Shiku, H., & Furukawa, K. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1122 · Cited by 96
A PCR-based method for the analysis of human CD44 splice products.Preprint
van Weering, D. H. J., Baas, P. D., & Bos, J. L. (1993) · Genome Research · doi:10.1101/gr.3.2.100 · Cited by 95
Green, S. J., Tarone, G., & Underhill, C. B. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90393-x · Cited by 92
To metastasize or not? Selection of CD44 splice sites
Cooper, D. L., & Dougherty, G. J. (1995) · Nature Medicine · doi:10.1038/nm0795-635 · Cited by 87
CD44 -- A New Prognostic Marker for Neuroblastoma
Favrot, M., Combaret, V., & Lasset, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312233292615 · Cited by 87
Goldstein, L. A., & Butcher, E. C. (1990) · Immunogenetics · doi:10.1007/bf00241632 · Cited by 83
The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells
Nemec, R. E., Toole, B. P., & Knudson, W. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91632-9 · Cited by 80
Neame, S. J., & Isacke, C. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05578.x · Cited by 79
Kugelman, L. C., Ganguly, S., Haggerty, J. G., Weissman, S. M., & Milstone, L. M. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12614896 · Cited by 79
Cooper, D. L., Dougherty, G. J., Harn, H., Jackson, S., Baptist, E. W., Byers, J., Datta, A., Phillips, G., & Isola, N. R. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91770-q · Cited by 74
Gansauge, F., Gansauge, S., Zobywalski, A., Scharnweber, C., Link, K. H., Nussler, A. K., & Beger, H. G. (1995) · PubMed · Cited by 72
Reber, S., Matzku, S., Günthert, U., Ponta, H., Herrlich, P. A., & Zöller, M. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460528 · Cited by 67
Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44
Sinn, H., Heider, K., Skroch, P., von Minckwitz, G., Kaufmann, M., Herrlich, P. A., & Ponta, H. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00713402 · Cited by 65
Z�ller, M. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00202261 · Cited by 65
Kugelman, L. C., Ganguly, S., Haggerty, J. G., Weissman, S. M., & Milstone, L. M. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616092 · Cited by 52
Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia
Yu, Q., & Toole, B. P. (1997) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199701)208:1<1::aid-aja1>3.0.co;2-m · Cited by 50
Expression of CD44 isoforms in human prostate tumor cell lines
Stevens, J. W., Palechek, P. L., Griebling, T. L., Midura, R. J., Rokhlin, O. W., & Cohen, M. B. (1996) · The Prostate · Cited by 46
Cell locomotion and chemotaxis
Zigmond, S. H. (1989) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(89)80041-9 · Cited by 38
Cited by
Pre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Senbanjo, L. T., & Chellaiah, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00018 · Cited by 842
Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration
Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H., & Seiki, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.893 · Cited by 746
Hyaluronic acid for anticancer drug and nucleic acid delivery
Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596
Hyaluronan–CD44 interactions as potential targets for cancer therapy
Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08071.x · Cited by 494
Metadata
- Authors
- Sneath, R. J., & Mangham, D. C.
- Venue
- Molecular Pathology
- Publisher
- BMJ
- Published
- 1998-08-01
- Volume
- 51
- Issue
- 4
- Pages
- 191-200
- ISSN
- 1366-8714 (ISSN-L)
- OpenAlex
- W2136138562
- Cited by
- 332
- References
- 79
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.